BioStartup News Newsletter
Press Releases, Financial News,
Media Coverage, Careers and Events |
* - May need subscription or registration to view |
|
|
FOUNDATION PARTNER
|
|
|
|
|
PRESS RELEASES
|
|
|
- Anebulo Pharmaceuticals: Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer More
- Athos Therapeutics: Abraham Verghese MD, Noted Stanford Physician and Recipient of the National Humanities Medal at the White House From Former President Obama, Appointed to the Board of Directors More
- C2N Diagnostics: Introduces P-tau Multi-Analyte Assay for Research Use Only to Advance Alzheimer's Disease and Brain Health Field More More
- Dermavant: FDA Approves VTAMA (tapinarof) Cream, 1% for the Treatment of Plaque Psoriasis in Adults: First Topical Novel Chemical Entity Launched for Psoriasis in the U.S. in 25 Years More More
- Elevation Oncology: FDA Fast Track Designation Granted to Seribantumab for the Tumor-Agnostic Treatment of Solid Tumors Harboring NRG1 Gene Fusions More
- IO Biotech: Initiation of Phase 3 Combination Trial of IO102-IO103 and KEYTRUDA (pembrolizumab) as First-Line Treatment in Advanced Melanoma More
- MAIA Biotechnology: Establishes Wholly Owned Subsidiaries in Romania and Australia to Support Global Development of THIO More
- Neuronascent: Receives FDA Rare Pediatric Drug Designation for NNI-351 Treatment for Fragile X Syndrome More
- Noveome Biotherapeutics: Receives Rare Pediatric Disease Designation and Orphan Drug Designation for the Treatment of Necrotizing Enterocolitis in Neonates More
- Ocuphire: Positive Topline Results From LYNX-1 Phase 3 Trial Evaluating Nyxol Eye Drops for Night Vision Disturbances More
- Phathom Pharmaceuticals: Presents Data on Novel Potassium-Competitive Acid Blocker (PCAB) Vonoprazan From a Range of Studies at Digestive Disease Week (DDW) 2022 More
- Quantgene: Offers 12 Hour RT-PCR COVID-19 Tests for $99 More
- SpringWorks Therapeutics: Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase 3 DeFi Trial in Adult Patients With Progressing Desmoid Tumors More
- Starton Therapeutics: Approval to Proceed with Final Dose Escalation in Phase 1 Clinical Study Evaluating STAR-LLD More
- Umoja Biopharma and Lupagen: New Collaboration to Improve Patient Experience and Access to Next-Generation In Vivo Therapeutics for Cancer More
- Umoja Biopharma: Presents New Preclinical Data at ASGCT 2022 Annual Meeting on its VivoVec Platform Describing Preclinical Safety Data for UB-VV100 Product Candidate, VivoVec Engineering for Improved in vivo CAR T cell Generation and Development of a Scalable Manufacturing Platform More
- VenoStent Technology: Receives Breakthrough Device Designation by FDA More
|
MISPRO ANNOUNCES NEW LOCATION IN WALTHAM BIOPHARMA CLUSTER
Learn More
|
|
|
FINANCIAL NEWS
|
|
|
- Biotech Stocks Are Getting Crushed — But Industry Insiders Say There's Reason for Optimism More
- Brii Biosciences: Will Be Added to MSCI China Small Cap Index More
- Celularity: $30 Million Private Placement Priced At-the-Market Under Nasdaq Rules More
- CND Life Sciences: Awarded NIH SBIR Grant to Study Novel Skin Biopsy Test for Dementias More
- CytoDyn: Resolution of Legal Dispute With Former Chief Medical Officer More
- Inceptor Bio: $37 Million Series A Financing More More More More
- Miga Health Raises $12M Seed Round to Build Heart Health App More
- RTP's Locus Biosciences Closes $35M Series B, Investors Include J&J and Tencent More
- Zentalis Pharmaceuticals: Closing of Underwritten Offering of Common Stock More
- ZZ Biotech: Stroke Drug Moves Closer to Pivotal Phase 3 Clinical Trial as the NIH Awards First Tranche of $30 Million Grant to the Keck School of Medicine of USC More
HOT INVESTOR MANDATES from MAY 19
- Hot Investor Mandate: Family Office-Backed Financial Services Firm Actively Seeks New Investment Opportunities With Strong Interests in Therapeutics & Diagnostics More
- Hot Investor Mandate: USA Fund of Large Asia-Based VC Firm Invests Up to $10M With Broad Interests in All Life Science Companies Based in North America and Europe More
- Hot Investor Mandate: USA-Based Private Investment Firm Seeks Venture and Growth-Stage Opportunities in Clinical Stage and Close to Commercialization More
- Hot Investor Mandate: Early-Stage Life Sciences Accelerator & VC Firm Invests Up to $40M in Pre-Clinical Therapeutics Companies in CNS, Oncology, and More More
|
|
SECTION SPONSOR: |
|
|
|
|
|
MEDIA/MISC COVERAGE
|
|
|
- BIOBUZZ: In Conversation With Gary Fanger, Ph.D., Founder, President, and CEO Podcast
- BioPharma Startup Opens Fishers HQ More
- 'From a Trickle to a Waterfall': How Biotech's Flow is Growing in DFW More
- Mason Biotech Startup Virongy Continues to Expand in Northern Virginia More
- Most Recent Tweets From BioStartup News More
- New Apprenticeship Program Focuses on Life Sciences Industry Across NC More
- Out On The (Cutting) Edge: How the Tools of Extreme Survival Can Help Build a Biotech Company More
- Portland Biotech Aims Not to Make Vaccines but Make Them Better More
- StartUPDATES: New Developments From Healthcare Startups More
- Startup Hustle: New Orleans Leading Biotech Startup Podcast
- Two Women-Led Startups Look to Solve Baby-Formula Crisis With Synthetic Breast Milk More
- Wait for the Exit or Jump Ship? Here’s What You Need to Ask Yourself More
|
|
SECTION SPONSOR: |
|
|
|
|
|
EVENT CENTER
|
|
|
|
|
SECTION SPONSOR: |
|
|
|
DON'T MISS THE NEWS AND DEVELOPMENTS FROM THE "BIG 4" BIOTECH HUBS IN THE WORLD!
SUBSCRIBE NOW TO BIG4BIO'S DAILY NEWSLETTERS
|
|
|
|
CAREER CENTER
|
|
|
- Lab Operations Associate, MOMA Therapeutics - Boston, MA More
- Medical Laboratory Technologist - 1st Shift, OpenTrons - Long Island City, NY More
- National Director - Field Medical, Day One Biopharmaceuticals - Remote More
- Director, Discovery Analytical Chemistry, Eikon Therapeutics - Hayward, CA More
- QC Contractor, Tenaya Therapeutics - Union City, CA More
- Principal Clinical Research Associate, Mirum Pharmaceuticals - Remote More
|
|
SECTION SPONSOR: |
|
|
|
|
|
SPONSORS
|
|
|
|
|
|